This 6-K is a scheduling notice with no standalone trading signal. The event to watch is the August 20, 2026 Q2 results/business update — for a clinical-stage company with a roughly $27M market cap, the focus will be on cash position, runway, and any pipeline catalysts. Avoid pre-positioning based on this notice alone.
Price Chart
Executive Summary
Evaxion A/S filed a Form 6-K on August 14, 2026, announcing that it will release a business update and Q2 2026 financial results on August 20, 2026, before the Nasdaq CM open, followed by a conference call and webcast. This is a routine earnings-date notification with no financial figures or new clinical data disclosed.
Key Facts
- Evaxion will report Q2 2026 financial results and provide a business update on August 20, 2026, before market open.
- Executive management will host a conference call and webcast on August 20, 2026 at 14:30 CET / 08:30 EST.
- Press release dated August 14, 2026 was furnished as Exhibit 99.1 to the 6-K.
- No financial figures, guidance, or clinical pipeline updates were included in this filing.
Financial Impact
No financial figures disclosed in this filing — the announcement only schedules the Q2 2026 results and business update for August 20, 2026.
Risk Factors
- No financial data provided — elevated binary event risk at the August 20 earnings release.
- Clinical-stage TechBio profile implies potential need for additional capital, which may dominate the upcoming update.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-005527 |
| Exhibit: exh_991.htm | 0001171843-26-005527 |
| Document: 0001171843-26-005527-index-headers.html | 0001171843-26-005527 |
| Document: 0001171843-26-005527-index.html | 0001171843-26-005527 |
| Document: 0001171843-26-005527.txt | 0001171843-26-005527 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $3.07 $3.21 | ▲ +4.56% | ▲ +4.45% | $3.21 (+4.63%) |
Sep 4, 2026 28d ago | 6-K | $3.12 $3.07 | ▲ +1.60% | ▲ +0.39% | $3.21 (−2.96%) |
Aug 20, 2026 6w ago | 6-K | $3.28 $3.15 | ▼ −3.96% | ▼ −5.08% | $3.21 (−2.07%) |
Aug 20, 2026 6w ago | Press Release | $3.28 $3.15 | ▼ −3.96% | ▼ −5.08% | $3.21 (−2.07%) |
Aug 17, 2026 6w ago | 6-K | $3.13 $3.40 | ▲ +8.63% | ▲ +9.82% | $3.21 (+2.63%) |
Aug 14, 2026 7w ago | 6-K | $3.34 $3.31 | ▼ −0.90% | ▲ +0.47% | $3.21 (−3.83%) |
Aug 14, 2026 7w ago | Press Release | $3.34 $3.31 | ▼ −0.90% | ▲ +0.47% | $3.21 (−3.83%) |
Jul 17, 2026 11w ago | 6-K | $3.08 $3.05 | ▼ −0.81% | ▼ −0.13% | $3.21 (+4.46%) |
Jul 17, 2026 11w ago | Press Release | $3.08 $3.05 | ▼ −0.81% | ▼ −0.13% | $3.21 (+4.46%) |
Jul 13, 2026 11w ago | 6-K | $3.02 $3.08 | ▲ +1.82% | ▲ +2.61% | $3.21 (+6.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access